Assessment of Immunogenicity, Reactogenicity and Safety of the Drug GNG-DE in Comparison With the Reference Drug

NCT06834100 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections
Meningococcal

Interventions

DRUG: polysaccharide conjugated vaccine for prevention of meningococcal infection of serogroups A, C, W, Y

Sponsor

NPO Petrovax